← Back to Search

Clinical Outcome Assessment Development for Opioid Use Disorder

N/A

Recruiting

Led By Cecilia L Bergeria, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up sessions 1, 2, and 3 after cue-induced craving task (approximately 1 hour into session)

Awards & highlights

Study Summary

This trial is collecting information about opioid craving in order to develop a better assessment for treatments of opioid use disorder.

Who is the study for?

This trial is for adults over 18 who are currently in treatment for opioid use disorder and have tested positive for opioids, excluding those on Naltrexone. It's not open to individuals with other substance disorders (except nicotine), pregnant or breastfeeding women, those at risk of incarceration, intoxicated persons, or people with recent suicidal behavior or serious psychiatric issues.Check my eligibility

What is being tested?

The study aims to develop an assessment tool for measuring opioid craving by having participants engage with neutral items and opioid-related images and objects. They will then discuss their experiences in interviews and complete questionnaires about their cravings.See study design

What are the potential side effects?

Since this trial involves assessments rather than medication, there are no direct side effects from drugs. However, the process may trigger psychological discomfort due to exposure to opioid-related cues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ sessions 1, 2, and 3 after cue-induced craving task (approximately 1 hour into session)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~sessions 1, 2, and 3 after cue-induced craving task (approximately 1 hour into session)

This trial's timeline: 3 weeks for screening, Varies for treatment, and sessions 1, 2, and 3 after cue-induced craving task (approximately 1 hour into session) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Acceptability of Craving Assessments

Change in Craving Domains

Change in Deficits in Craving Assessments

Secondary outcome measures

Change in Predictive utility of craving assessment items

Trial Design

1Treatment groups

Experimental Treatment

Group I: No CravingExperimental Treatment3 Interventions

Each participant will attend three sessions where the participant will experience three distinct cue-induced craving tasks in a randomized fashion.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,468 Previous Clinical Trials

2,619,267 Total Patients Enrolled

Johns Hopkins UniversityLead Sponsor

2,260 Previous Clinical Trials

14,820,699 Total Patients Enrolled

Cecilia L Bergeria, PhDPrincipal InvestigatorJohns Hopkins University

1 Previous Clinical Trials

3 Total Patients Enrolled

Media Library

Visual and Tactile Opioid Cue-induced Craving Clinical Trial Eligibility Overview. Trial Name: NCT05109429 — N/A

Opioid Use Disorder Research Study Groups: No Craving

Opioid Use Disorder Clinical Trial 2023: Visual and Tactile Opioid Cue-induced Craving Highlights & Side Effects. Trial Name: NCT05109429 — N/A

Visual and Tactile Opioid Cue-induced Craving 2023 Treatment Timeline for Medical Study. Trial Name: NCT05109429 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to partake in this clinical trial at the moment?

"Clinicaltrials.gov confirms that this trial is open for enrolment since its initial posting on March 3rd, 2022 and amendment of the same day."

Answered by AI

How many individuals have signed up to participate in this research project?

"Affirmative. The details available on clinicaltrials.gov demonstrate that this medical trial is currently accepting participants for enrollment. It was initially posted on March 3rd 2022 and recently modified a few days ago, also on the 3rd of March. There are 81 slots open at one specific site location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Developing a Clinical Outcome Assessment for Opioid Craving

2022. "Developing a Clinical Outcome Assessment for Opioid Craving". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05109429.